Rocket Pharmaceuticals (RCKT)
(Delayed Data from NSDQ)
$18.59 USD
+0.10 (0.54%)
Updated Aug 23, 2024 04:00 PM ET
After-Market: $18.58 -0.01 (-0.05%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/4/24 |
---|---|
Current Quarter | -0.77 |
EPS Last Quarter | -0.74 |
Last EPS Surprise | 0.00% |
ABR | 1.21 |
Earnings ESP
|
-2.25% |
---|---|
Current Year | -2.97 |
Next Year | -2.42 |
EPS (TTM) | -2.79 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | 11.64M | 68.73M |
# of Estimates | NA | NA | 1 | 5 |
High Estimate | NA | NA | 11.64M | 112.90M |
Low Estimate | NA | NA | 11.64M | 21.80M |
Year ago Sales | 0.00M | 0.00M | NA | 11.64M |
Year over Year Growth Est. | NA | NA | NA | 490.34% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.77 | -0.78 | -2.97 | -2.42 |
# of Estimates | 7 | 6 | 9 | 7 |
Most Recent Consensus | -0.80 | -0.81 | -3.00 | -2.36 |
High Estimate | -0.67 | -0.67 | -2.71 | -1.51 |
Low Estimate | -0.84 | -0.85 | -3.12 | -3.21 |
Year ago EPS | -0.75 | -0.64 | -2.92 | -2.97 |
Year over Year Growth Est. | -2.67% | -21.88% | -1.71% | 18.38% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 4 | 4 |
Up Last 60 Days | 1 | 0 | 3 | 3 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 4 | 4 | 4 | 2 |
Down Last 60 Days | 4 | 5 | 5 | 3 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.77 | -0.78 | -2.97 | -2.42 |
7 Days Ago | -0.77 | -0.78 | -2.97 | -2.42 |
30 Days Ago | -0.74 | -0.75 | -2.96 | -2.31 |
60 Days Ago | -0.68 | -0.57 | -2.85 | -2.01 |
90 Days Ago | -0.68 | -0.57 | -2.85 | -1.87 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.79 | -0.80 | -3.00 | -2.51 |
Zacks Consensus Estimate | -0.77 | -0.78 | -2.97 | -2.42 |
Earnings ESP | -2.25% | -2.27% | -1.09% | -3.46% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.74 | -0.66 | -0.64 | -0.75 | NA |
Estimate | -0.74 | -0.69 | -0.80 | -0.82 | NA |
Difference | 0.00 | 0.03 | 0.16 | 0.07 | 0.07 |
Surprise | 0.00% | 4.35% | 20.00% | 8.54% | 8.22% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more